Islet 1 Antibody (Rabbit mAb) [K5C1]

CatNo: F5224

    Application: Reactivity:
    • Lane 1: SH-SY5Y, Lane 2: Hela, Lane 3: A375, Lane 4: A431
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min

    使用情報

    Dilution
    1:1000 - 1:10000
    1:10 - 1:100
    1:6000
    Application
    WB, IP, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    39 kDa 39 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human small cell lung carcinoma tissue; Human pancreas tissue; Human gastric neuroendocrine carcinoma tissue; SH-SY5Y cells; HAP1 cells; HepG2 cells; HeLa cells; A375 cells; A431 cells; K562 cells; Jurkat cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Islet 1 Antibody (Rabbit mAb) [K5C1] detects endogenous levels of total Islet 1 protein.
    タンパク質の局在
    細胞核
    Uniprot ID
    P61371
    Clone
    K5C1
    Synonym(s)
    Insulin gene enhancer protein ISL-1, Islet-1, ISL1
    Background
    Islet‑1 (ISL1) is a LIM‑homeodomain transcription factor of the LIM family that remains expressed in all adult pancreatic endocrine lineages and functions as a central regulator of endocrine cell differentiation, postnatal islet proliferation and β‑cell gene expression, integrating developmental signals with transcriptional control of hormone production and secretion. The protein contains two N‑terminal LIM domains that mediate protein–protein interactions with cofactors such as Ldb1, Set7/9 and PDX‑1, and a C‑terminal homeodomain that binds DNA at regulatory elements of endocrine genes, creating a modular structure that couples sequence‑specific promoter and enhancer recognition to assembly of multi‑protein transcriptional complexes. During pancreas development, ISL1 is required for the survival and differentiation of pancreatic endocrine progenitors and later acts together with the coregulator Ldb1 to control the development of α‑, β‑ and δ‑cells; genetic studies show that Ldb1 mediates much of LIM‑HD and LIM‑only factor activity in islets and that loss of Ldb1 disrupts endocrine cell development, highlighting a pathway in which ISL1–Ldb1 complexes drive lineage‑specific transcription programs. In the postnatal pancreas, ISL1 maintains β‑cell identity and function by regulating expression of key genes such as insulin, MafA, Glut2 and Pdx1; conditional Isl1 deletion in β‑cells leads to reduced insulin content, impaired glucose‑stimulated insulin secretion and progressive diabetes, demonstrating that ISL1 is essential not only for endocrine specification but also for mature β‑cell function. Mechanistically, ISL1 promotes islet cell proliferation by forming an ISL1/Set7/9/PDX‑1 complex that binds promoters of genes involved in β‑cell growth and insulin synthesis, where Set7/9 provides histone methyltransferase activity and PDX‑1 contributes pancreatic lineage specificity, and disruption of any component reduces islet proliferation and insulin gene transcription, defining a cooperative transcriptional module that links chromatin modification to endocrine expansion. In the broader islet niche, ISL1‑dependent transcription interacts with paracrine and vascular signals that shape β‑cell structure and secretory behavior, and proteomic and functional studies indicate that ISL1‑regulated networks participate in the adaptation of islets to metabolic stress, connecting transcription factor activity to changes in lipid metabolism, cytokine signaling and β‑cell resilience in type 2 diabetes. Genetic or expression alterations of ISL1 and its co‑regulators are associated with impaired β‑cell proliferation, defective insulin secretion and increased susceptibility to type 2 diabetes, and ISL1 has also been implicated in congenital heart and motor neuron development in other contexts, reflecting the reuse of LIM‑homeodomain transcription modules across excitable tissues.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください